Central venous catheter complications in sickle cell disease
β Scribed by Michael R. Jeng; James Feusner; Christine Skibola; Elliott Vichinsky
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 82 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A one-year prospective study to evaluate the use of central venous catheters in intensive treatment of patients with acute blood malignancies was performed. Fortyseven catheters in 29 patients were studied. In spite of thrombocytopenia in several patients, no severe bleeding episodes were observed.
In their article on the neurological complications of sickle cell disease, Prengler and colleagues 1 present an excellent review of the central nervous system complications of sickle cell anemia. They do, however, omit peripheral nervous system complications that we believe require some mention. Per
Peripheral blood stem cell harvest by apheresis is an increasingly important procedure utilized in the treatment of many malignancies. Whether autologous or allogeneic, it is frequently performed via peripheral access because of concern over major complications associated with central venous cathete
Sickle cell anemia and the related hemoglobinopathies are associated with a large spectrum of renal abnormalities. The patients have impaired urinary concentrating ability, defects in urinary acidification and potassium excretion, and supranormal proximal tubular function. The latter is manifest by